Target Price | $48.96 |
Price | $43.38 |
Potential | 12.86% |
Number of Estimates | 16 |
16 Analysts have issued a price target Exelon 2026 . The average Exelon target price is $48.96. This is 12.86% higher than the current stock price. The highest price target is $54.60 25.86% , the lowest is $37.37 13.85% . | |
A rating was issued by 21 analysts: 10 Analysts recommend Exelon to buy, 9 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Exelon stock has an average upside potential 2026 of 12.86% . Most analysts recommend the Exelon stock at Purchase. |
15 Analysts have issued a sales forecast Exelon 2025 . The average Exelon sales estimate is $24.3b . This is 2.26% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $25.5b 7.26% , the lowest is $23.0b 3.43% .
This results in the following potential growth metrics:
2024 | $23.0b | 5.99% |
---|---|---|
2025 | $24.3b | 5.53% |
2026 | $25.0b | 2.79% |
2027 | $25.7b | 2.78% |
2028 | $26.8b | 4.42% |
2029 | $27.8b | 3.57% |
15 Analysts have issued an Exelon EBITDA forecast 2025. The average Exelon EBITDA estimate is $8.9b . This is 6.42% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $9.6b 14.67% , the lowest is $8.3b 0.84% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $7.9b | 5.08% |
---|---|---|
2025 | $8.9b | 12.86% |
2026 | $9.6b | 7.37% |
2027 | $10.3b | 7.40% |
2028 | $10.8b | 5.47% |
2029 | $11.5b | 5.88% |
2024 | 34.31% | 0.86% |
---|---|---|
2025 | 36.69% | 6.94% |
2026 | 38.33% | 4.47% |
2027 | 40.05% | 4.49% |
2028 | 40.45% | 1.00% |
2029 | 41.35% | 2.22% |
18 Exelon Analysts have issued a net profit forecast 2025. The average Exelon net profit estimate is $2.7b . This is 3.54% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.9b 8.33% , the lowest is $2.7b 0.10% .
This results in the following potential growth metrics and future Net Margins:
2024 | $2.5b | 5.67% |
---|---|---|
2025 | $2.7b | 11.67% |
2026 | $2.9b | 4.66% |
2027 | $3.1b | 6.41% |
2028 | $3.3b | 7.10% |
2029 | $3.5b | 7.31% |
2024 | 10.68% | 0.30% |
---|---|---|
2025 | 11.30% | 5.78% |
2026 | 11.51% | 1.86% |
2027 | 11.91% | 3.48% |
2028 | 12.22% | 2.60% |
2029 | 12.66% | 3.60% |
18 Analysts have issued a Exelon forecast for earnings per share. The average Exelon EPS is $2.72 . This is 3.42% higher than earnings per share in the financial year 2024. The highest EPS forecast is $2.85 8.37% , the lowest is $2.63 0.00% .
This results in the following potential growth metrics and future valuations:
2024 | $2.45 | 4.70% |
---|---|---|
2025 | $2.72 | 11.02% |
2026 | $2.85 | 4.78% |
2027 | $3.03 | 6.32% |
2028 | $3.24 | 6.93% |
2029 | $3.48 | 7.41% |
Current | 16.49 | 4.79% |
---|---|---|
2025 | 15.95 | 3.30% |
2026 | 15.24 | 4.45% |
2027 | 14.32 | 6.04% |
2028 | 13.37 | 6.63% |
2029 | 12.46 | 6.81% |
Based on analysts' sales estimates for 2025, the Exelon stock is valued at an EV/Sales of 3.78 and an P/S ratio of 1.80 .
This results in the following potential growth metrics and future valuations:
Current | 3.87 | 5.74% |
---|---|---|
2025 | 3.78 | 2.25% |
2026 | 3.68 | 2.72% |
2027 | 3.58 | 2.71% |
2028 | 3.43 | 4.23% |
2029 | 3.31 | 3.45% |
Current | 1.84 | 10.11% |
---|---|---|
2025 | 1.80 | 2.20% |
2026 | 1.75 | 2.72% |
2027 | 1.71 | 2.71% |
2028 | 1.63 | 4.23% |
2029 | 1.58 | 3.45% |
Analyst | Rating | Action | Date |
---|---|---|---|
Keybanc |
Underweight
➜
Underweight
|
Unchanged | Jul 16 2025 |
UBS |
Neutral
➜
Neutral
|
Unchanged | Jul 11 2025 |
UBS |
Neutral
➜
Neutral
|
Unchanged | Jun 02 2025 |
Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | May 22 2025 |
Keybanc |
Sector Weight
➜
Underweight
|
Downgrade | May 14 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | May 02 2025 |
Evercore ISI Group |
In-Line
➜
In-Line
|
Unchanged | May 02 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Keybanc:
Underweight
➜
Underweight
|
Jul 16 2025 |
Unchanged
UBS:
Neutral
➜
Neutral
|
Jul 11 2025 |
Unchanged
UBS:
Neutral
➜
Neutral
|
Jun 02 2025 |
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
May 22 2025 |
Downgrade
Keybanc:
Sector Weight
➜
Underweight
|
May 14 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
May 02 2025 |
Unchanged
Evercore ISI Group:
In-Line
➜
In-Line
|
May 02 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.